GEN Exclusives

More »

GEN News Highlights

More »
Aug 9, 2007

Tripos Inks Library Analysis Agreement with Elan

  • Tripos Discovery Research (TDR) will assist Elan Pharmaceuticals in analyzing and enhancing the diversity of its small molecule screening collection.

    TDR will perform computational clustering of key subsets and determine optimal areas for expansion. The company also will provide high-throughput quality control analyses of legacy compounds via mass spectrometry.

    Applying its computational design and therapeutic medicinal chemistry tools, TDR says that it is able to reduce drug discovery timelines by up to 30%.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »